Outcome of patients with inconsistent results from 13C-urea breath test and bacterial culture at the time of assessment of Helicobacter pylori eradication therapy in Japan
- PMID: 14571821
Outcome of patients with inconsistent results from 13C-urea breath test and bacterial culture at the time of assessment of Helicobacter pylori eradication therapy in Japan
Abstract
Background/aims: At the assessment of eradication therapy of Helicobacter pylori, the results of 13C-urea breath test and other methods such as bacterial culture are occasionally inconsistent. In this study, we examined the outcomes of inconsistent results.
Methodology: Four hundred and four patients with peptic ulcer who were H. pylori-positive and who had completed eradication therapy were studied. Bacterial culture, rapid urease tests and 13C-urea breath test were performed between one and three months after the end of the therapy. The cut-off value for the 13C-urea breath test used originally in this study was 2.5 per mil. We investigated the outcome of inconsistent results by following up the patients every 6 to 12 months.
Results: At the initial assessment of eradication therapy, we observed inconsistent results with bacterial culture and 13C-urea breath test in 43 of 404 patients. Most of them (40 of 43) were culture-negative but urea breath test-positive, and the majority became negative for both tests. Based on the follow-up results, the optimum value for 13C-urea breath test at the assessment of eradication therapy was found to be 3.5 per mil.
Conclusions: We found that outcomes of inconsistent results were variable, indicating the importance of the follow-up of patients after eradication therapy of H. pylori.
Similar articles
-
Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?Dig Liver Dis. 2006 Apr;38(4):254-9. doi: 10.1016/j.dld.2005.10.022. Epub 2005 Nov 22. Dig Liver Dis. 2006. PMID: 16309984
-
[13C]urea breath test to confirm eradication of Helicobacter pylori.Am J Gastroenterol. 1995 Feb;90(2):224-6. Am J Gastroenterol. 1995. PMID: 7847290
-
Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment.Rev Esp Enferm Dig. 2003 Feb;95(2):121-6, 115-20. Rev Esp Enferm Dig. 2003. PMID: 12760719 Clinical Trial. English, Spanish.
-
[13C-urea breath test].Nihon Rinsho. 2001 Feb;59(2):267-71. Nihon Rinsho. 2001. PMID: 11218396 Review. Japanese.
-
[The appropriate time for the assessment of Helicobacter pylori eradication].Nihon Rinsho. 1999 Jan;57(1):111-5. Nihon Rinsho. 1999. PMID: 10036946 Review. Japanese.
Cited by
-
Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases.J Gastroenterol. 2007 Jan;42 Suppl 17:21-7. doi: 10.1007/s00535-006-1924-9. J Gastroenterol. 2007. PMID: 17238021 Clinical Trial.
-
Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study.J Gastroenterol. 2015 Jun;50(6):638-44. doi: 10.1007/s00535-014-1004-5. Epub 2014 Oct 29. J Gastroenterol. 2015. PMID: 25351555
-
Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan.J Gastroenterol. 2012 Jun;47(6):641-6. doi: 10.1007/s00535-012-0536-9. Epub 2012 Feb 17. J Gastroenterol. 2012. PMID: 22350696
-
The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori.J Gastroenterol. 2011 Mar;46(3):318-24. doi: 10.1007/s00535-010-0347-9. Epub 2010 Nov 20. J Gastroenterol. 2011. PMID: 21103997
-
Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication.J Gastroenterol. 2020 Mar;55(3):281-288. doi: 10.1007/s00535-019-01639-w. Epub 2019 Oct 30. J Gastroenterol. 2020. PMID: 31667586 Free PMC article.
MeSH terms
LinkOut - more resources
Medical